{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:20:40Z","timestamp":1787314840588,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T00:00:00Z","timestamp":1386806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11102-013-0544-7","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T22:37:57Z","timestamp":1386715077000},"page":"557-563","source":"Crossref","is-referenced-by-count":41,"title":["Impact of treatment satisfaction on quality of life of patients with acromegaly"],"prefix":"10.1007","volume":"17","author":[{"given":"Hasan","family":"Kepicoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Hatipoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Darici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naz","family":"Hizli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,12]]},"reference":[{"issue":"1","key":"544_CR1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102\u2013152","journal-title":"Endocr Rev"},{"issue":"11","key":"544_CR2","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1210\/jc.2011-1645","volume":"96","author":"J Tiemensma","year":"2011","unstructured":"Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR (2011) Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly. J Clin Endocrinol Metab 96(11):3550\u20133558. doi: 10.1210\/jc.2011-1645","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"544_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.beem.2009.05.010","volume":"23","author":"P Chanson","year":"2009","unstructured":"Chanson P, Salenave S, Kamenicky P, Cazabat L, Young J (2009) Pituitary tumours: acromegaly. Best Pract Res Clin Endocrinol Metab 23(5):555\u2013574. doi: 10.1016\/j.beem.2009.05.010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"544_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-08-0267","volume":"159","author":"IM Holdaway","year":"2008","unstructured":"Holdaway IM, Bolland MJ, Gamble GD (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159(2):89\u201395. doi: 10.1530\/EJE-08-0267","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"544_CR5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2007.02891.x","volume":"67","author":"AN Paisley","year":"2007","unstructured":"Paisley AN, Rowles SV, Roberts ME, Webb SM, Badia X, Prieto L, Shalet SM, Trainer PJ (2007) Treatment of acromegaly improves quality of life, measured by AcroQol. Clin Endocrinol 67(3):358\u2013362. doi: 10.1111\/j.1365-2265.2007.02891","journal-title":"Clin Endocrinol"},{"issue":"6","key":"544_CR6","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2004-1565","volume":"90","author":"SV Rowles","year":"2005","unstructured":"Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90(6):3337\u20133341. doi: 10.1210\/jc.2004-1565","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"544_CR7","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1210\/jc.2006-0676","volume":"91","author":"R Kauppinen-Makelin","year":"2006","unstructured":"Kauppinen-Makelin R, Sane T, Sintonen H, Markkanen H, Valimaki MJ, Loyttyniemi E, Niskanen L, Reunanen A, Stenman UH (2006) Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab 91(10):3891\u20133896. doi: 10.1210\/jc.2006-0676","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"544_CR8","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1210\/jc.2004-0669","volume":"89","author":"NR Biermasz","year":"2004","unstructured":"Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89(11):5369\u20135376. doi: 10.1210\/jc.2004-0669","journal-title":"J Clin Endocrinol Metab"},{"key":"544_CR9","doi-asserted-by":"crossref","first-page":"268957","DOI":"10.1155\/2012\/268957","volume":"2012","author":"U Plockinger","year":"2012","unstructured":"Plockinger U (2012) Medical therapy of acromegaly. Int J Endocrinol 2012:268957. doi: 10.1155\/2012\/268957","journal-title":"Int J Endocrinol"},{"issue":"4","key":"544_CR10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1530\/EJE-11-0853","volume":"166","author":"MR Postma","year":"2012","unstructured":"Postma MR, Netea-Maier RT, van den Berg G, Homan J, Sluiter WJ, Wagenmakers MA, van den Bergh AC, Wolffenbuttel BH, Hermus AR, van Beek AP (2012) Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. Eur J Endocrinol 166(4):585\u2013592. doi: 10.1530\/EJE-11-0853","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"544_CR11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.2007.03169.x","volume":"69","author":"AA Klaauw van der","year":"2008","unstructured":"van der Klaauw AA, Biermasz NR, Hoftijzer HC, Pereira AM, Romijn JA (2008) Previous radiotherapy negatively influences quality of life during 4\u00a0years of follow-up in patients cured from acromegaly. Clin Endocrinol 69(1):123\u2013128. doi: 10.1111\/j.1365-2265.2007.03169.x","journal-title":"Clin Endocrinol"},{"issue":"6","key":"544_CR12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF02599549","volume":"4","author":"DS Brody","year":"1989","unstructured":"Brody DS, Miller SM, Lerman CE, Smith DG, Caputo GC (1989) Patient perception of involvement in medical care: relationship to illness attitudes and outcomes. J Gen Intern Med 4(6):506\u2013511","journal-title":"J Gen Intern Med"},{"issue":"2","key":"544_CR13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3122\/15572625-13-2-124","volume":"13","author":"TR Taylor","year":"2000","unstructured":"Taylor TR (2000) Understanding the choices that patients make. J Am Board Fam Pract 13(2):124\u2013133","journal-title":"J Am Board Fam Pract"},{"issue":"7","key":"544_CR14","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141\u20133148. doi: 10.1210\/jc.2009-2670","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"544_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2265.2002.01597.x","volume":"57","author":"SM Webb","year":"2002","unstructured":"Webb SM, Prieto L, Badia X, Albareda M, Catala M, Gaztambide S, Lucas T, Paramo C, Pico A, Lucas A, Halperin I, Obiols G, Astorga R (2002) Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol 57(2):251\u2013258","journal-title":"Clin Endocrinol"},{"key":"544_CR16","unstructured":"Deyneli O, Yavuz D, Gozu H, Aydin H, Bicer D, Topcuoglu V, Akalin SN (2003) Evaluation of quality of life in Turkish patients with acromegaly. In: Proceedings of the 84th annual meeting of endocrine society. Phidelphia, pp 3\u2013508"},{"issue":"3\u20134","key":"544_CR17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000095532","volume":"83","author":"SM Webb","year":"2006","unstructured":"Webb SM (2006) Quality of life in acromegaly. Neuroendocrinology 83(3\u20134):224\u2013229. doi: 10.1159\/000095532","journal-title":"Neuroendocrinology"},{"key":"544_CR18","volume-title":"Handbook of psychiatric measures","author":"AT Beck","year":"2008","unstructured":"Beck AT, Steer RA, Brown GK (2008) Beck depression inventory (BDI). In: Rush AJ, First MB, Blacker D (eds) Handbook of psychiatric measures, 2nd edn. American Psychiatric Publishing Inc., Washington, DC","edition":"2"},{"key":"544_CR19","first-page":"118","volume":"22","author":"N Hisli","year":"1988","unstructured":"Hisli N (1988) A study on the validity of The Beck Depression Inventory. Turkish J Psychol 22:118\u2013126","journal-title":"Turkish J Psychol"},{"key":"544_CR20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-2-12","volume":"2","author":"MJ Atkinson","year":"2004","unstructured":"Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR (2004) Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2:12. doi: 10.1186\/1477-7525-2-12","journal-title":"Health Qual Life Outcomes"},{"issue":"Suppl 1","key":"544_CR21","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1524-4733.2005.00066.x","volume":"8","author":"MJ Atkinson","year":"2005","unstructured":"Atkinson MJ, Kumar R, Cappelleri JC, Hass SL (2005) Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health 8(Suppl 1):S9\u2013S24. doi: 10.1111\/j.1524-4733.2005.00066.x","journal-title":"Value Health"},{"issue":"2","key":"544_CR22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1745790413480521","volume":"13","author":"MD Kaplan","year":"2013","unstructured":"Kaplan MD, Kasnako\u00fc\u011flu BT, Yigitbasi T, Kaplan YC (2013) Evaluation of satisfaction with over-the-counter weight loss supplements. J Med Mark Device Diagn Pharma Mark 13(2):68\u201373","journal-title":"J Med Mark Device Diagn Pharma Mark"},{"issue":"12","key":"544_CR23","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1210\/jc.2007-1234","volume":"92","author":"SJ Neggers","year":"2007","unstructured":"Neggers SJ, van Aken MO, Janssen JA, Feelders RA, de Herder WW, van der Lely AJ (2007) Long-term efficacy and safety of combined treatment of somatostatin analogs and pegvisomant in acromegaly. J Clin Endocrinol Metab 92(12):4598\u20134601. doi: 10.1210\/jc.2007-1234","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"544_CR24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000329189","volume":"76","author":"SJ Neggers","year":"2011","unstructured":"Neggers SJ, van der Lely AJ (2011) Pegvisomant and improvement of quality of life in acromegalic patients. Horm Res Paediatr 76(Suppl 1):102\u2013105. doi: 10.1159\/000329189","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"544_CR25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1530\/eje.1.02292","volume":"155","author":"SC Hua","year":"2006","unstructured":"Hua SC, Yan YH, Chang TC (2006) Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly. Eur J Endocrinol 155(6):831\u2013837. doi: 10.1530\/eje.1.02292","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-013-0544-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-013-0544-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-013-0544-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:08:20Z","timestamp":1559354900000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-013-0544-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1007\/s11102-013-0544-7","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,12]]}}}